Volume 2 – Number 4

>

Fully automated thrombin generation assays: current characteristics, advances, and clinical relevance

>

First report of renal replacement therapy using hemodialysis in a patient with severe hemophilia B in Uruguay: a clinical challenge

>

Celebrating half a century of collaboration in hemostasis and thrombosis: the first 50 years of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT Group)

>

Corrigendum in the article by D.C. Castillo-González et al. Implementation of a work system for the introduction of emicizumab in Cuba

>

Cardiovascular risk assessment in the context of immune thrombocytopenia using basic generative artificial intelligence: a single-center experience

>

Editorial.

>

Efanesoctocog alfa: a new standard for haemophilia A prophylaxis?